Nanomaterials for Skin Cancer Photoimmunotherapy
Skin cancer is one of the most common types of cancer, and its incidence continues to increase. It is divided into two main categories, melanoma and non-melanoma. Treatments include surgery, radiation therapy, and chemotherapy.
Carlota M. Relvas +4 more
doaj +4 more sources
Overcoming Resistant Cancerous Tumors Through Combined Photodynamic and Immunotherapy (Photoimmunotherapy) [PDF]
Cancer is a major health problem as it causes significant mortality globally. In the last decades, conventional and recent therapeutic approaches have been used in oncology for cancer treatment.
Heidi Abrahamse
exaly +4 more sources
Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent And/Or Metastatic Head and Neck Squamous Cell Carcinoma [PDF]
Background ASP-1929 photoimmunotherapy-cetuximab conjugated to IRDye 700DX and red light (690 nm) for localized drug activation-results in rapid, selective cell killing.Methods This phase Ib/II open-label study evaluated ASP-1929 photoimmunotherapy plus ...
Katharine A Price
exaly +3 more sources
Cerium End-Deposited Gold Nanorods-Based Photoimmunotherapy for Boosting Tumor Immunogenicity
Background: Triple-negative breast cancer (TNBC) was closely related to high metastatic risk and mortality and has not yet found a targeted receptor for targeted therapy.
Yanlin Feng +7 more
doaj +2 more sources
EGFR-targeted photoimmunotherapy and its association with the immune microenvironment in locoregional recurrent head and neck squamous cell carcinoma [PDF]
BackgroundEpidermal growth factor receptor (EGFR)-targeted photoimmunotherapy using cetuximab sarotalocan sodium (RM-1929) represents a novel therapeutic modality that induces selective tumor cell death and may influence the tumor immune microenvironment
Koichi Yoshizawa +21 more
doaj +2 more sources
NIR-II emissive nanomedicine of dimer-structured conjugated oligomer induces immunogenic cell death for photoimmunotherapy of pancreatic cancer [PDF]
Pancreatic cancer is a highly immunosuppressive “cold” tumor that typically fails to achieve satisfactory immunotherapy outcomes. Photoimmunotherapy represents a preeminent cancer treatment strategy that combines the advantages of noninvasive ...
Cui Cen +13 more
doaj +2 more sources
The low immunogenicity, insufficient infiltration of T lymphocytes, and dismal response to immune checkpoint blockade therapy pose major difficulties in immunotherapy of pancreatic cancer.
Mingyue Zheng, Haijun Yu, Feisheng Zhong
exaly +2 more sources
Transurethral resection of bladder tumor (TURBT) followed by intravesical therapy remains the most effective strategy for the management of non-muscle-invasive bladder cancer worldwide.
Xiaofeng Yang, Liu Chao, Yongjun Yang
exaly +3 more sources
Breaking the selectivity-uptake trade-off of photoimmunoconjugates with nanoliposomal irinotecan for synergistic multi-tier cancer targeting [PDF]
Background Photoimmunotherapy involves targeted delivery of photosensitizers via an antibody conjugate (i.e., photoimmunoconjugate, PIC) followed by light activation for selective tumor killing.
Barry J. Liang +5 more
doaj +2 more sources
In situ photoimmunotherapy is ineffective in treating deeply invasive squamous cell carcinoma
In situ photoimmunotherapy (ISPI) can be a treatment option for selected cutaneous malignancies in patients who are not surgical candidates. We herein report the case of a large, ulcerating poorly differentiated squamous cell carcinoma (SCC) affecting ...
Tak-Wah Wong +2 more
doaj +2 more sources

